Sage Therapeutics, Inc. - Common Stock (NQ:SAGE)

8.680 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 30, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Sage Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Sage (SAGE) Q2 Revenue Jumps 264% ↗

August 01, 2025

Via The Motley Fool

Acadia Emerges From Behind The Scenes With A Potential $12 Billion Opportunity ↗

July 10, 2025

Acadia Pharmaceuticals is working on its next-generation Nuplazid and, for CEO Catherine Owen Adams, the journey is personal.

Via Investor's Business Daily

Topics Intellectual Property

Beyond The Numbers: 6 Analysts Discuss Sage Therapeutics Stock ↗

July 08, 2025

Via Benzinga

Sage Therapeutics Stock: JPMorgan Sees 8% Downside After Supernus Buyout Terms ↗

June 22, 2025

Analysts have also noted that the relatively low breakup fee may leave room for a competing offer, possibly from Biogen.

Via Stocktwits

Deep Dive Into Sage Therapeutics Stock: Analyst Perspectives (4 Ratings) ↗

June 17, 2025

Via Benzinga

Earnings Scheduled For April 29, 2025 ↗

April 29, 2025

Via Benzinga

What to Expect from Sage Therapeutics's Earnings ↗

April 28, 2025

Via Benzinga

A Glimpse Into The Expert Outlook On Sage Therapeutics Through 7 Analysts ↗

February 12, 2025

Via Benzinga

These Analysts Revise Their Forecasts On Sage Therapeutics Following Acquisition News ↗

June 17, 2025

Via Benzinga

Top 3 Health Care Stocks That Are Ticking Portfolio Bombs ↗

June 17, 2025

Via Benzinga

US Stock Futures Tumble After Trump Threatens 'Real End' To Iran's Nuclear Problem: '...Avoid Getting Whipsawed By Noise,' Says Expert ↗

June 17, 2025

U.S. stock futures were trading lower on Tuesday following Monday's advanced. Futures of major benchmark indices were lower in premarket.

Via Benzinga

Topics Government

Dow Surges Over 300 Points As Iran Signals De-Escalation: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone ↗

June 17, 2025

Via Benzinga

Topics Stocks

Monday's session: top gainers and losers ↗

June 16, 2025

Curious to know what's happening on the US markets one hour before the close of the markets on Monday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

S&P 500 Surges 1%; New York Manufacturing Activity Tumbles In June ↗

June 16, 2025

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 16, 2025

Via Benzinga

Top movers in Monday's session ↗

June 16, 2025

Stay up-to-date with the latest market trends in the middle of the day on Monday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Supernus Pharmaceuticals Gets Retail Excited Over $795M Acquisition Plan For Sage Therapeutics ↗

June 16, 2025

Under the terms of the deal, Supernus is looking to acquire Sage for a total consideration of $12 per share in cash.

Via Stocktwits

Topics Government

Sage Therapeutics, Roku, EchoStar And Other Big Stocks Moving Higher On Monday ↗

June 16, 2025

Via Benzinga

These stocks are gapping in today's session ↗

June 16, 2025

In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down.

Via Chartmill

Supernus Pharma Acquires Maker Of Postpartum Depression Drug Zurzuvae In $795 Million Deal ↗

June 16, 2025

Supernus to acquire Sage Therapeutics for $795 million, gaining Zurzuvae and aiming for $200 million in annual cost synergies by expanding its CNS portfolio.

Via Benzinga

Beleaguered Sage Snapped Up In Deal Worth Up To $561 Million ↗

June 16, 2025

The deal expands Supernus Pharmaceuticals' presence in the nonpsychiatric space.

Via Investor's Business Daily

Topics ETFs

Monday's pre-market session: top gainers and losers ↗

June 16, 2025

Let's have a look at what is happening on the US markets before the opening bell on Monday. Below you can find the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 16, 2025

Via Benzinga

Expert Outlook: Sage Therapeutics Through The Eyes Of 4 Analysts ↗

April 25, 2025

Via Benzinga

US Stocks Likely To Open Mixed: 'Expect Volatility. Buckle Up,' Says Expert ↗

March 27, 2025

U.S. stock futures were swinging between gains and losses on Thursday after snapping a three-day winning streak on Wednesday. Futures of major benchmark indices were mixed in premarket trading. Aiming...

Via Benzinga

Topics Supply Chain World Trade

KB Home Posts Downbeat Results, Joins UniFirst, Oklo And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

March 25, 2025

Via Benzinga

Why Power Solutions International Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket ↗

March 25, 2025

Via Benzinga

What To Expect From Alzheimer's Drugmaker Biogen's Q4 Earnings On Wednesday? ↗

February 11, 2025

Biogen faces revenue challenges as Leqembi sales lag projections. Investors watch its pipeline expansion and strategic moves amid upcoming Q4 earnings.

Via Benzinga

Deal Dispatch: Sage And Silvus Are Up For Sale, MrBeast Secures $20B For TikTok ↗

January 31, 2025

Sage Therapeutics rejects Biogen deal offer; Silvus Technologies considers sale/IPO; Allakos downsizes; MrBeast bids on TikTok.

Via Benzinga

Earnings Scheduled For February 11, 2025 ↗

February 11, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.